Last reviewed · How we verify
A Study to Assess the Mass Balance and ADME of [14C]AZD5004 and the Absolute Bioavailability of AZD5004
This study in healthy volunteers aims to answer these questions: * Does the test medicine cause any important side effects? * What are the blood levels of the test medicine and how quickly does the body get rid of it? * How much of the test medicine taken by mouth gets into the bloodstream? * How does the body break down and get rid of the test medicine? This study will take place at one site in Nottingham, United Kingdom, and plans to enrol 8 healthy men aged 30-65 years, who will be involved in both parts of the study.
Details
| Lead sponsor | AstraZeneca |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 8 |
| Start date | Thu Mar 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon May 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Healthy Participants
Interventions
- AZD5004 film-coated tablet
- [14C]AZD5004 Solution for Infusion
- [14C]AZD5004 Oral Solution
Countries
United Kingdom